Basel Medical Group Ltd’s Lock-Up Period Set To Expire on August 25th (NASDAQ:BMGL)

Basel Medical Group’s (NASDAQ:BMGL) lock-up period is set to end on Monday, August 25th. Basel Medical Group had issued 2,205,000 shares in its public offering on February 25th. The total size of the offering was $8,820,000 based on an initial share price of $4.00. After the end of Basel Medical Group’s lock-up period, major shareholders and company insiders will be able to sell their shares of the company.

Wall Street Analyst Weigh In

Separately, Wall Street Zen lowered Basel Medical Group from a “hold” rating to a “sell” rating in a research note on Saturday, June 21st.

Basel Medical Group Trading Down 3.9%

NASDAQ BMGL opened at $1.97 on Monday. The stock’s fifty day moving average is $2.44. Basel Medical Group has a fifty-two week low of $0.91 and a fifty-two week high of $9.40.

Basel Medical Group Company Profile

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement.